Small Grant Support for Colleges/Schools of Pharmacy
Future Pharmacists Grant Program
NABP-AACP District IV recognizes the role of pharmacy students in shaping the future of the profession. The purpose of this program is to support projects that promote and advance the public health. The projects must be carried out by students from District IV (Wisconsin, Michigan, Ohio, Indiana and Illinois) colleges or schools of pharmacy in conjunction with one or more community partners. The grant is intended to provide seed money to develop sustainable programs (programs that can continue beyond the grant period). The projects must have measurable outcomes, and serve as templates that can be implemented by interested groups elsewhere in the country.
The District IV Board has designated electronic cigarettes/vaping as the topic for this grant cycle. Proposals submitted for this cycle should be relevant to pharmacy practice, academic pharmacy and/or state boards of pharmacy.
Electronic Nicotine Delivery Systems
In 2015, the popular electronic cigarette (e-cigarette) company, Juul[i] entered the market with a mission to render cigarettes obsolete. Using new technology, Juul and similar companies created Electronic Nicotine Delivery Systems (ENDS). Many of their products looked nothing like cigarettes, although they still contained nicotine.[ii]
Within a short time, middle and high school students were using ENDS in unusually large numbers, partly due to the attractive delivery forms and flavors in which they are available. In December 2018, the tobacco giant Altria (which owns the Marlboro cigarette brand), bought a 35% stake in Juul (approximately $13 Million), perhaps seeing it as an attractive alternative to cigarettes. On January 31 2019, Altria reported that Juul sales skyrocketed to $1 billion in 2018, up from $200m in the previous year.
In 2018, the Food and Drug Administration (FDA) reported that there were 3.62 million current users of e-cigarettes, and that from 2017 to 2018, e-cigarette use increased by 78% among high school students and 48% among middle school students. The increased number of youth using ENDS prompted FDA Commissioner Scott Gottlieb to issue a statement[iii] that labeled youth vaping as an epidemic and a public health concern. He announced a series of actions the FDA would take to address these trends.
Scientific research is not conclusive on the safety of e-cigarettes.[iv] Much of the scientific research available has illustrated increasing use of e-cigarettes among teens.[v] The FDA’s statement has led to an examination of why vaping is so dangerous.[vi] However, there is considerable debate regarding whether potential damage from teen vaping is overridden by its potential to help people stop smoking.[vii] [viii]
As future health care providers in regular contact with the community, you as a pharmacy student can potentially impact middle school and high school students’ ENDS products usage. Possible opportunities to affect change directly exist with students, family members, school faculty, law enforcement and other interested community-oriented groups.
District IV will support sustainable projects that can implement problem-solving ideas to address vaping and ENDS use among high school and middle school students. The projects submitted must have community partner involvement. Project partners can include any community groups that deal with vaping and the use of ENDS products by middle and high school students. These may include law enforcement groups, parent groups, social and health organizations, government agencies, legislative offices, professional associations, and state boards of pharmacy.
One major goal of this grant is to establish and strengthen ties between student groups and their community partners. The projects should have clear objectives that will be attained during the project.
All participating partners must have a relevant role in the project. The student organization must take the leadership role.
This award is not intended to support current activities, but to assist in establishing new ones.
The maximum funding request is $3,000. The District IV Board reserves the right to make more than one award, not to exceed this funding amount.
All student groups and professional chapter organizations in colleges/schools of pharmacy located in District IV are encouraged to apply.
One proposal will be accepted per college/school. The project must have a full-time faculty member at the college/school as an advisor.
Timeline of Key Dates
|February, 2018||Announcement/Application period begins|
|September 2, 2019||Online applications due to the District IV website by 5 PM Central Time/ 6 PM Eastern|
|September to October, 2019||Application review period|
November 7 – 9, 2019
Awardees formally announced at District IV Annual Meeting hosted by Purdue University and the Indiana State Board of Pharmacy
|November 12, 2019||Project/Activity period begins|
|February 25, 2020||Mid-project report due|
|June 30, 2020||Project/Activity period ends|
|July 30, 2020||Final Project Report due from awardee(s) and financial report due to grant administrator|
|November 2020||One student representative presents the project report at the District IV Annual Meeting hosted by The Ohio State University and the State of Ohio Board of Pharmacy|
The primary evaluation criteria are provided in the evaluation rubric (see below). Under the direction of the Executive Director of the District IV Board, reviewers will be appointed to evaluate the proposals.
Click on the following image to see scoring breakdown:
Must be clear, detailed and appropriate.
- No funding is available for charges incurred outside the project period.
- Funding for supplies/equipment is limited to items essential to the project. Applicants are encouraged to outline a plan for what happens to equipment after completion of the project. Equipment maintenance or repair is not eligible for funding.
- Consult your school/college of pharmacy or university Institutional Review Board (IRB) for approval of using human subjects in research.
Note: If you receive the award, funds not used at the end of the project period must be returned to District IV.
All funding requests must be justified in narrative form (maximum of 1 page). Applicants are advised to consider that the review committee relies heavily on the narrative budget explanation and justification when making decisions about funding.
Should you have any questions regarding the grant project, please contact:
Walter Siganga, Ph.D., Professor of Pharmaceutical Sciences
Email – email@example.com Specify “District IV Grant” in the Subject line.
Phone – 618-650-5135
[ii] US Food and Drug Administration. Vaporizers, E-Cigarettes and other Electronic Nicotine Delivery Systems. https://www.fda.gov/tobaccoproducts/labeling/productsingredientscomponents/ucm456610.htm – Last accessed January 27, 2019.
[iii] US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to address epidemic of youth e-cigarette use. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620185.htm – Last accessed January 27, 2019.
[iv] Digital Trends. Are e-cigarettes safe? Here’s what the most recent science says. https://www.digitaltrends.com/cool-tech/are-e-cigarettes-safe/ – Last accessed February 5, 2019.
[vi] Business Insider. The FDA id preparing to crack down on e-cigs like Juul – here’s why vaping is so dangerous. https://www.businessinsider.com/vaping-e-cigs-juul-health-effects-2018-10 – Last accessed February 5, 2019
[vii] Berry KM, Fetterman JL, Benjamin EJ et.al. Association of Electronic Cigarette Use With Subsequent Initiation of Tobacco Cigarettes in US Youths. JAMA Network Open. 2019;2(2):e187794.doi:10.1001/jamanetworkopen. 2018. 7794
[viii] Hajek P, Phillips Waller A, Przulj D. et. al. (2019) A Randomized Trial of E-Cigarette versus Nicotine- Replacement Therapy. New Engl J Med DOI: 10.1056/NEJMoa1808779